XML 63 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Equity
$ in Millions
USD ($)
shares
Previously Reported
USD ($)
Revision of Prior Period, Adjustment
USD ($)
[1]
Total NIQ Shareholders’ Equity
USD ($)
Total NIQ Shareholders’ Equity
Previously Reported
USD ($)
Total NIQ Shareholders’ Equity
Revision of Prior Period, Adjustment
USD ($)
[1]
Ordinary Shares
USD ($)
shares
Ordinary Shares
Previously Reported
USD ($)
shares
Ordinary Shares
Revision of Prior Period, Adjustment
shares
[1]
Preferred Shares
USD ($)
shares
Preferred Shares
Previously Reported
USD ($)
shares
Euro Deferred Shares
USD ($)
shares
Paid-In Capital
USD ($)
Paid-In Capital
Previously Reported
USD ($)
Paid-In Capital
Revision of Prior Period, Adjustment
USD ($)
[1]
Accumulated Deficit
USD ($)
Accumulated Deficit
Previously Reported
USD ($)
Accumulated Deficit
Revision of Prior Period, Adjustment
USD ($)
[1]
Accumulated Other Comprehensive (Loss) Income
USD ($)
Noncontrolling Interests
USD ($)
Noncontrolling Interests
Previously Reported
USD ($)
Beginning balance (in shares) at Dec. 31, 2022 | shares             245,000,000 [1] 100 244,999,900     0                  
Beginning balance (in shares) at Dec. 31, 2022 | shares                   0 [1] 0                    
Beginning balance at Dec. 31, 2022 $ 527.3 [1] $ 541.8 $ (14.5) $ 525.8 [1] $ 540.3 $ (14.5) $ 0.0 [1] $ 0.0   $ 0.0 [1] $ 0.0 $ 0.0 $ 924.0 [1] $ 951.4 $ (27.4) $ (473.3) [1] $ (486.2) $ 12.9 $ 75.1 [1] $ 1.5 [1] $ 1.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Net (loss) income (573.6)     (577.4)                       (577.4)       3.8  
Other comprehensive (loss) income 5.6     5.6                             5.6    
Contribution from Parent [2] 1,011.3     1,011.3                 1,011.3                
Shared-based compensation 4.3     4.3                 4.3                
Acquisition of subsidiaries 253.0                                     253.0  
Cash dividends paid to noncontrolling interests (11.1)                                     (11.1)  
Ending balance (in shares) at Dec. 31, 2023 | shares             245,000,000         0                  
Ending balance (in shares) at Dec. 31, 2023 | shares                   0                      
Ending balance at Dec. 31, 2023 1,216.8     969.6     $ 0.0     $ 0.0   $ 0.0 1,939.6     (1,050.7)     80.7 247.2  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Offering expenses $ 0.0                                        
Effective share split 0.0000004081632653                                        
Net (loss) income $ (791.7)     (798.0)                       (798.0)       6.3  
Other comprehensive (loss) income (118.4)     (118.4)                             (118.4)    
Contribution from Parent [2] 1.8     1.8                 1.8                
Shared-based compensation 4.7     4.7                 4.7                
Cash dividends paid to noncontrolling interests $ (14.6)                                     (14.6)  
Ending balance (in shares) at Dec. 31, 2024 | shares 245,000,000           245,000,000         0                  
Ending balance (in shares) at Dec. 31, 2024 | shares 0                 0                      
Ending balance at Dec. 31, 2024 $ 298.6     59.7     $ 0.0     $ 0.0   $ 0.0 1,946.1     (1,848.7)     (37.7) 238.9  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Offering expenses 0.0                                        
Net (loss) income (345.3)     (353.3)                       (353.3)       8.0  
Other comprehensive (loss) income 5.7     5.7                             5.7    
Issuance of share capital in connection with IPO net of underwriting discounts, commissions and offering expenses (in shares) | shares [3],[4]             50,000,000         25,000                  
Issuance of share capital in connection with IPO net of underwriting discounts and commissions and offering expenses [3],[4] 984.1     984.1                 984.1                
Shared-based compensation 43.0     43.0                 43.0                
Reclassification of warrant to equity 231.1     231.1                 231.1                
Reclassification of phantom to equity 18.1     18.1                 18.1                
Cash dividends paid to noncontrolling interests $ (9.7)                                     (9.7)  
Ending balance (in shares) at Dec. 31, 2025 | shares 295,000,000           295,000,000         25,000                  
Ending balance (in shares) at Dec. 31, 2025 | shares 0                 0                      
Ending balance at Dec. 31, 2025 $ 1,225.6     $ 988.4     $ 0.0     $ 0.0   $ 0.0 $ 3,222.4     $ (2,202.0)     $ (32.0) $ 237.2  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Offering expenses $ 21.7                                        
Beginning balance (in shares) at Jul. 21, 2025 | shares 100                                        
Ending balance (in shares) at Jul. 22, 2025 | shares 245,000,000                                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Effective share split 0.0000004081632653                                        
[1] Prior to the common control transaction, the Company had 100 ordinary shares outstanding. Following the common control transaction, the Company will have 245,000,000 ordinary shares outstanding, resulting in an effective share split of 1:2,450,000. See Note 2. “Summary of Significant Accounting Policies” for discussion around the Company’s common control transaction and updated basis of presentation.
[2] Contribution from Parent was a non-cash contribution mainly related to equity consideration transferred as part of the transaction to combine with GfK SE, as described in Note 3. “Acquisitions”.
[3] Represents aggregate net proceeds of $985.1 million after deducting underwriting discounts and commissions and estimated offering expenses at the initial public offering date less additional offering expense and other adjustments of $1.0 million recognized subsequent to the initial public offering date.
[4] The Euro deferred shares were issued in order to satisfy statutory capitalization requirements for all Irish public limited companies. The Euro deferred shares are non-voting shares and do not have any right to receive a dividend.